top of page

Stargardt Macular Degeneration

Behaviour

    Blurry or distorted vision
    Color vision difficulties
    Light sensitivity
    Preserved peripheral vision
    Visual fatigue

Biomarkers

    ABCA4 gene mutations
    Optical Coherence Tomography (OCT)
    Fundus Autofluorescence (FAF)
    Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO)

Pathology

    Genetic basis
    Lipofuscin accumulation
    RPE dysfunction
    Juvenile macular degeneration
    Photoreceptor damage

Retinitis Pigmentosa (RP)

Behaviour

    Progressive peripheral vision loss
    Difficulty with mobility
    Night blindness
    Light sensitivity (photophobia)
    Anxiety, depression, and feelings of isolation

Biomarkers

    Fundus Autofluorescence (FAF)
    Optical Coherence Tomography (OCT)
    Electroretinogram (ERG)
    Visual field testing

Pathology

    Photoreceptor cell death
    Retinal pigment epithelial atrophy
    Retinal pigment deposits
    Rod-cone dystrophy

Diabetic Retinopathy

Behaviour

    Blurred vision
    Floaters
    Distorted vision
    Vision loss
    Color vision changes

Biomarkers

    HbA1c
    Interleukin-6 (IL-6)
    Retinol-binding protein 4 (RBP4)
    Afamin (AFM)
    Apolipoproteins

Pathology

    Capillary microaneurysms
    Retinal hemorrhages
    Oxidative stress
    Retinal hypoxia
    Breakdown of the blood-retina barrier

Uveitis

Behaviour

    Eye pain
    Red eyes
    Blurred vision
    Sensitivity to light
    Floaters

Biomarkers

    Optical coherence tomography (OCT)
    Cytokines: TNF-α, IL-17, IL-23, and IL-8
    CRALBP, MDH
    Thrombospondin (TSP-2)

Pathology

    Cell injury
    Cyclitic membrane
    Immune response
    Granulomatous and nongranulomatous
    Adhesions

Geographic Atrophy (GA)

Behaviour

    Progressive vision loss
    Early symptoms may be subtle
    Blurred or distorted central vision
    Impact on daily activities: reading, driving
    Reduced night vision

Biomarkers

    CFH gene
    LOC387715/ARMS2/HTRA1
    C2, C3
    Inflammatory cytokines: CRP

Pathology

    Progression: RPE
    Visual impact
    Photoreceptor cells
    Underlying mechanisms: genetic predisposition, chronic inflammation, oxidative stress

Diabetic macular edema (DME)

Behaviour

    Progressive vision loss
    Blurred vision
    Color perception changes
    Difficulty with glare
    No pain

Biomarkers

    Intraretinal fluid
    SRF
    Subretinal fluid (SRF)
    Disorganization of the retinal inner layers (DRIL)

Pathology

    Blood-retinal barrier breakdown
    Hyperglycemia-induced damage
    Vascular endothelial growth factor (VEGF)
    Pericyte loss
    Oxidative stress

Glaucoma
(Open-Angle Glaucoma)

Behaviour

    Stress
    Eye pain or pressure
    Headaches
    Blurred vision, double vision
    Red eye

Biomarkers

    Aqueous humor proteins: OPN, MMP-9, TNF-alpha, TGF-beta, IL-10
    Crystallins, heat shock protein 60, HSP 90, myotrophin
    VDAC2, PGAM1, and CALD1
    Brain-derived neurotrophic factor (BDNF)
    Ankyrin-2

Pathology

    Optic nerve damage
    Trabecular meshwork abnormalities
    Optic nerve cupping
    Intraocular pressure (IOP)
    Retinal ganglion cell death

Macular Degeneration (AMD - Age-related Macular Degeneration)

Behaviour

    Difficulty reading
    Frustration and anxiety
    Social isolation
    Distorted vision
    Blind spots in central vision

Biomarkers

    CFH
    PLEKHA1/ARMS2/HtrA1 genes
    SERPING1
    COL8A1

Pathology

    Retinal pigment epithelium (RPE)
    Oxidative stress
    Mitochondrial DNA damage
    Complement attack

Hypertensive Retinopathy (HR)

Behaviour

    Blurred or double vision
    Reduced visual clarity
    Headaches
    Eye strain
    Sudden vision loss

Biomarkers

    Retinal vascular parameters
    Ischemia modified albumin (IMA)
    Serum uric acid
    Microalbuminuria
    Direct retinal observation

Pathology

    Arteriolar changes
    Arteriovenous (AV) nicking
    Macular star
    Stroke
    Heart attack

Dry Eye Syndrome

Behaviour

    Frequent blinking
    Eye rubbing
    Squinting
    Eyelid discomfort
    Blurred vision, redness

Biomarkers

    Lactoferrin
    Lysozyme
    Tear Osmolarity
    Matrix metalloproteinase-9 (MMP-9)
    Cytokines: IL-1β, TNF-α, IL-6

Pathology

    Tear film instability
    Meibomian gland dysfunction (MGD)
    Increased osmolarity
    Decreased tear production
    Ocular surface damage
bottom of page